Schedule 13G ownership disclosure
SILO PHARMA INC COM
Common Stock, $0.0001 par value per share · CUSIP: 82711P201
Event date: 2026-02-13
- Filing-level shares
- 0.00
- Percent of class
- 0.0%
- SEG Opportunity Fund, LLC
Shares: 0.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-26-016071
- Form type
- SCHEDULE 13G/A
- Filer
- SEG Opportunity Fund, LLC
- CIK
- CIK 2041952
- Filed
- Feb 13, 2026
- Reporting period
- Feb 13, 2026
- Description
- Schedule 13G beneficial ownership